Cell and Gene Therapy (CGT)

In the field of cell and gene therapy (CGT), BioEngine has developed multiple serum-free media with independent intellectual property rights, which includes HIPP series serum-free medium for in vitro culture and expansion of immune cells (CAR-T, NK, CAR-NK, etc.), Vigor series serum-free medium for AAV (adeno-associated virus) production on insect cells, and Celer series serum-free medium for AAV (adeno-associated virus) and LV (lentivirus) production on 293 cells. These cell culture media are applied in cell culture the research and production in the field of CGT, and have supported the completion of IND projects for CGT companies.